WELL Health Technologies Corp. revised revenue guidance for the year 2024. The company increases its guidance range for 2024 annual revenue of between $960 million to $980 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.68 CAD | 0.00% | -3.16% | -4.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.42% | 654M | |
+20.12% | 85.16B | |
-2.68% | 25.79B | |
+3.31% | 17.67B | |
-15.31% | 16.23B | |
+0.22% | 15.35B | |
+75.22% | 13.49B | |
+74.08% | 12.85B | |
+40.02% | 12.87B | |
+1.03% | 12.17B |
- Stock Market
- Equities
- WELL Stock
- News WELL Health Technologies Corp.
- WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024